Inspire Veterinary Plunges 18.86% on Revenue Decline

Inspire Veterinary's stock price plummeted by 18.86% in pre-market trading on August 15, 2025, marking a significant downturn for the company.

In the second quarter of 2025, Inspire Veterinary reported a 7% decrease in product revenue, totaling $1.1 million. This decline was attributed to customers purchasing fewer products. Additionally, the company's overall revenue for the quarter was $4.28 million, a 2.4% decrease from the previous year's $4.39 million. Despite the revenue decline, the company's net loss narrowed to $3.03 million, or $0.50 per share, compared to the previous year's $0.70 per share.

Inspire Veterinary has implemented several operational improvements, including a 27% reduction in costs, the integration of AI for diagnostics, and employee incentives. These measures have helped to narrow the company's net losses to $3.0 million by the second quarter of 2025. The company's service revenue of $3.20 million outpaced product sales, which totaled $1.09 million. Comparable clinic revenues increased by 5.7% compared to the prior year period, indicating some positive developments despite the overall revenue decline.